Hepatitis C Challenge

123456789101112
Across
  1. 2. acronym for hepatitis attributed to hep c prior to discovery of the virus
  2. 4. name of medication often added to DAA regimen in patients with decompensated cirrhosis
  3. 6. patient who are co-infected with this virus are at increased risk of reactivation
  4. 7. brand name for combo DAA drug with all three classes of DAAs
  5. 9. name of drug that is a polymerase inhibitor
  6. 10. most common presentation of acute hepatitis c infection
  7. 12. number of genotypes of hep C
Down
  1. 1. brand name for combo DAA medication that should NOT be used for GT1 with NS5a resistance-associated substitutions
  2. 3. glecaprevir is a type of NS3 "blank" inhibitor
  3. 5. brand name for combo DAA medication safe to use in ESRD for all gentoypes
  4. 8. goal of treatment is a "blank" virologic response
  5. 11. patient population at risk of acquiring hep C